Nanomaterials continue to bring promising advances to science and technology. In concert have come calls for increased regulatory oversight to ensure their appropriate identification and evaluation, which has led to extensive discussions about nanomaterial definitions. Numerous nanomaterial definitions have been proposed by government, industry, and standards organizations. We conducted a comprehensive comparative assessment of existing nanomaterial definitions put forward by governments to highlight their similarities and differences. We found that the size limits used in different definitions were inconsistent, as were considerations of other elements, including agglomerates and aggregates, distributional thresholds, novel properties, and solubility. Other important differences included consideration of number size distributions versus weight distributions and natural versus intentionally-manufactured materials. Overall, the definitions we compared were not in alignment, which may lead to inconsistent identification and evaluation of nanomaterials and could have adverse impacts on commerce and public perceptions of nanotechnology. We recommend a set of considerations that future discussions of nanomaterial definitions should consider for describing materials and assessing their potential for health and environmental impacts using risk-based approaches within existing assessment frameworks. Our intent is to initiate a dialogue aimed at achieving greater clarity in identifying those nanomaterials that may require additional evaluation, not to propose a formal definition.
Introduction
Definitions of nanomaterials and their use in regulatory evaluations have been, and continue to be, an area of active scientific and policy debate (ICCA, 2010; Maynard, 2011; Stamm, 2011; Bleeker et al., 2013) . Nanomaterials may exhibit properties different from their non-nano forms, and these different properties have raised questions about potential human health and environmental risks. The International Organization for Standardization (ISO) has defined "nanomaterial" as a "material with any external dimension in the nanoscale or having internal structure or surface structure in the nanoscale" (ISO, 2010) and "nanoparticle" as a "nano-object with all three external dimensions in the nanoscale" where nanoscale is defined as the size range from approximately 1e100 nm (ISO, 2008) . These technical definitions, based on size only, may be insufficient from a risk evaluation standpoint because they do not include other important elements that should be considered when determining whether a nanomaterial may need additional review.
Discussions about developing a definition for nanomaterials have been challenging because of the need to satisfy two diverging considerations. A definition should be broad enough to define materials that may warrant additional evaluation, yet it should not be so broad as to include those materials for which additional examination or evaluation would not be meaningful in terms of protecting human health or the environment. A balance is necessary to ensure appropriate allocation of resources to most effectively protect the health and safety of humans and the environment. Definitions proposed to date have taken a variety of approaches in attempting to strike a suitable balance, but while they may satisfy specific jurisdictional mandates, their frequently contradictory inclusions and exclusions present a complex regulatory maze for producers of nanomaterials and products containing them. Difficulties associated with attempting to comply with contradictory nanomaterial definitions and potential regulations can impede international trade and, more fundamentally, reduce public confidence in the adequacy of regulatory protections.
Nanomaterials are neither inherently hazardous nor inherently safe (Auffan et al., 2009; Donaldson and Poland, 2013) , and it has been broadly recognized that they should not be treated as such in evaluation programs (SCENIHR, 2007; Holdren, 2011; Hamburg, 2012) . Likewise, the informational elements of a nanomaterial definition presented in this paper are not intended to identify inherently hazardous or non-hazardous materials. Rather, they are intended to be used in conjunction with available hazard and exposure information to identify nanoscale materials which may be of interest for potential priority setting, risk assessment, and risk management activities. While the elements we identify in this paper can help strengthen or inform developing definitions, they should not be viewed as a comprehensive list of factors to be considered in a safety assessment of nanomaterials. Regardless of the definition that is applied, there is an obligation of both regulators and the regulated community to ensure that a material is evaluated appropriately to determine whether it poses a risk to human health or the environment. This evaluation should be based not only on the intrinsic hazard potential of the material but on consideration of exposure potential (e.g. during manufacturing, use, and disposal) as well.
The purpose of this paper is twofold: (1) to compare and contrast existing nanomaterial definitions and (2) to present a set of informational elements to be considered as discussions on the need for definitions and nanomaterial regulatory frameworks continue. The intent is not to propose a formal definition for nanomaterials, but to initiate a dialogue aimed at achieving greater clarity in identifying those nanomaterials that may require additional evaluation. That process should account for each of the elements presented in this paper at some point in the evaluation, while seeking to eliminate differences that create further ambiguity. The ideas expressed in this paper apply to the commercial manufacturing and use of nanomaterials.
Comparison/contrast of current definitions
Numerous definitions for nanomaterials have been proposed by various government, industry, and standards organizations. These definitions are often inconsistent in their elements and scope, which can lead to confusion in determining whether a material is or is not considered to be a "nanomaterial." To better understand the similarities and differences among definitions, we performed a comprehensive comparative assessment of 14 definitions from various regulatory authorities (Table 1 ). The assessment included formal regulatory definitions as well as definitions stated in guidance or policy documents ("advisory definitions" in Table 1 ). The definitions are generally intended to address safety impacts to people and the environment, though there may appear to be a particular emphasis on human health impacts. The elements considered in this analysis are applicable for human and environmental safety, as well as toxicological and ecotoxicological effects.
Size (or external dimensions) was the only common element across all of the definitions, though the upper size limits were sometimes variable among the definitions. Several important core elements that were not consistently mentioned included: consideration of agglomerates and aggregates, distributional thresholds, novel properties, and solubility. Other important differences included number size distributions versus weight distributions and the inclusion of natural and incidental nanomaterials along with those manufactured intentionally. A summary of these core elements and the similarities and differences among the 14 definitions is presented in Table 2 . This comparative assessment highlights some of the key differences that can lead to a lack of clarity and consistency with respect to the term "nanomaterial" and what materials may be subject to existing or developing regulations. What follows is a discussion on some of the factors that should be considered when developing regulatory definitions or identifying nanomaterials that may be of interest, with a focus on those elements identified through the comparative assessment in Table 2 .
Core elements for describing nanomaterials

Size
Size is the fundamental defining characteristic of all nanomaterials. While size is an easy concept to understand, it is more difficult to apply because there are no natural physical or chemical boundaries that delineate the "nanoscale." By convention, 1e100 nm is the size range most commonly used in reference to nanomaterials, but there is no bright line that clearly demarks the nanoscale from a chemical or biological perspective. At the lower end of the range, 1 nm is intended to distinguish between individual molecules and nanomaterials, although some molecules (e.g., some proteins and biomolecules) may have at least one dimension larger than 1 nm. Many nanomaterial definitions explicitly include materials that may have dimensions below 1 nm (e.g., fullerenes and graphene; Table 2 ). At this lower end of "nanoscale," the characteristics and properties of the material are largely defined by the chemistry of the molecule and not by the physical nature of the formed nanoscale materials.
The upper end of the "nanoscale" at 100 nm is an arbitrary cutoff since the size-dependent behavior of materials does not stop or begin abruptly at 100 nm. Many properties characteristic of the nanoscale, such as solubility, light scattering, and surface area effects, are predictable and continuous characteristics of the bulk materials (Donaldson and Poland, 2013) . In an attempt to be inclusive of all the characteristics that may be important for regulatory oversight, some authorities have expanded the upper range of the nanoscale well beyond 100 nm (Table 2) (Health Canada, 2011; US FDA, 2011; Taiwan, 2012) .
While size limits are somewhat arbitrary, there is general agreement that any unique nano-specific phenomena of particulates are most likely to occur between 1 and 100 nm. For instance, the properties of inorganic particles were evaluated by Auffan et al. (2009) who found that novel, size-dependent properties of nanoscale materials, such as catalytic properties of gold, the photocatalytic activity of TiO 2 , and the tunable fluorescent behavior of quantum dots, occur below 30 nm (see the Novel Properties section of this paper for further discussion). Most regulatory authorities have used 1e100 nm to define the nanoscale, which is consistent with the ISO standard (ISO, 2008) . We agree that this provides a reasonable range, provided there is recognition that particle size alone is not sufficient for the evaluation of a nanomaterial and that "[I]ndustrial materials intentionally produced, manufactured or engineered to have unique properties or specific composition at the nanoscale, that is a size range typically between 1 nm and 100 nm, and is either a nano-object (i.e. that is confined in one, two, or three dimensions at the nanoscale) or is nanostructured (i.e. having an internal or surface structure at the nanoscale). Aggregates and agglomerates are included and apply to materials where 10% or more of the particles by number count meet the above definition."
All non-food Advisory Definition
Health Canada (Health-Canada, 2011) Health Canada considers any manufactured substance or product and any component material, ingredient, device, or structure to be nanomaterial if it is at or within the nanoscale in at least one external dimension, or has internal or surface structure at the nanoscale, or if it is smaller or larger than the nanoscale in all dimensions and exhibits one or more nanoscale properties/phenomena. Nanoscale properties/phenomena refer to properties that are attributable to the size of the substance and size effects.
All Advisory Definition
United States Food and Drug Administration (US FDA, 2011)
There is no formal agency definition. However, "when considering whether an FDA-regulated product contains nanomaterials, or otherwise involves the application of nanotechnology, FDA will ask: Whether an engineered material or end product has at least one dimension in the nanoscale range (approximately 1 nm to 100 nm); or whether an engineered material or end product exhibits properties or phenomena, including physical or chemical properties or biological effects, that are attributable to its dimension(s), even if these dimensions fall outside the nanoscale range, up to one micrometer."
Cosmetics, pharmaceuticals, food, and food contact
Advisory Definition
United States Environmental Protection Agency (US EPA, 2007 , 2011b There is no formal agency definition. However, the agency has outlined key criteria across several documents, including: solid at 25 C and atmospheric pressure, particle size between 1 and 100 nm in at least 1 dimension; the material exhibits unique and novel properties because of its size; the material is engineered at the nanoscale; inclusion of primary particles, aggregates and agglomerates; and a distribution of particles with greater than 10% by weight less than 100 nm. " 'Nanomaterial' means a natural, incidental or manufactured material containing particles, in an unbound state or as an aggregate or as an agglomerate and where, for 50% or more of the particles in the number size distribution, one or more external dimensions is in the size range 1 nme100 nm." "In specific cases and where warranted by concern for environment, health, safety or competitiveness the number size distribution threshold of 50% may be replaced by a threshold between 1 and 50%."
"[F]ullerenes, graphene flakes and single wall carbon nanotubes with one or more external dimensions below 1 nm should be considered as nanomaterials."
All Advisory Definition
European Parliament and the Council of the European Union on the provision of food information to consumers (EC, 2011b)
"'[E]ngineered nanomaterial' means any intentionally produced material that has one or more dimensions of the order of 100 nm or less or that is composed of discrete functional parts, either internally or at the surface, many of which have one or more dimensions of the order of 100 nm or less, including structures, agglomerates or aggregates, which may have a size above the order of 100 nm but retain properties that are characteristic of the nanoscale. "Properties that are characteristic of the nanoscale include: (i) those related to the large specific surface area of the materials considered; and/or (ii) specific physico-chemical properties that are different from those of the non-nanoform of the same material." " '[N]anomaterial' means a natural or manufactured active substance or non-active substance containing particles, in an unbound state or as an aggregate or as an agglomerate and where, for 50% or more of the particles in the number size distribution, one or more external dimensions is in the size range 1e100 nm. "Fullerenes, graphene flakes, and single wall carbon nanotubes with one or more external dimension below 1 nm shall be considered as nanomaterials."
Biocides Regulatory Definition
French Ministry of Ecology, Sustainable Development and Energy (ANSES, 2012)
"Substance at nanoscale" is defined as a substance "intentionally produced at nanometric scale, containing particles, in an unbound state or as an aggregate or as an agglomerate and where, for a minimum of 50% of particles in the number size distribution, one or more external dimensions is in the size range 1 nme100 nm. By derogation from this definition, fullerenes, graphene flakes and single-wall carbon nanotubes with one or more external dimensions below 1 nm are considered as 'substances at nanoscale'."
All Regulatory Definition
Taiwan Council of Labor Affairs (Taiwan, 2012) A nanomaterial is one which is intentionally manufactured or designed and meets any of the following conditions: A) Material with one or more external dimensions or an internal or surface structure on the scale from 1 to 100 nm;
B) It is smaller or larger than the nanoscale above in all spatial dimensions and exhibits one or more nanoscale phenomena/property (for example, increased intensity and chemical reactivity).
C) 13 engineered nanomaterials by OECD in 2010 which can be used as reference are provided in the definition.
All Advisory Definition
Swiss 
Regulatory Definition
Belgian Federal Public Service Health, Food Chain Safety and Environment (Belgium, 2014) "Substance produced in nanoparticular state" is defined as a substance containing unbound particles, or aggregate or agglomerate of those particles, where 50% or more of the particles in the number size distribution have one or more external dimension is in the size range of 1e100 nm. The definition excludes natural, non-chemically modified substances and those for which the fraction in the 1e100 nm range is "a byproduct of human activity," which is further defined. there should be adequate consideration given to the inclusion of the additional criteria discussed below.
Distributional thresholds and mass vs. particle number
An additional practical aspect of understanding how size defines a nano-object or nanomaterial is the size distribution around a median or mean. Few particulate substances are "monodisperse" (i.e., with a geometric standard deviation <2). Instead, most naturally occurring and manufactured nanomaterials have size distributions that may vary widely. Fig. 1A shows the hypothetical distribution of two particle populations with the same median size. For these two examples, the distribution varies greatly, but most of the particles are still in the nanoscale (less than 100 nm). However, if only a portion of the particles in the distribution is within the nanoscale, should that substance be considered a nanomaterial? Fig. 1B illustrates a particle size distribution in which only 10% of the particles fall within the nanoscale. Inclusion of a distributional size cut-off as a component of a definition is needed to provide increased clarity as to what should be considered a nanomaterial (Bleeker et al., 2013) . Many definitions include particle size distribution as an important consideration, though inconsistently. Some definitions define the particle size distribution based on the weight percentage, while others define it based on the number count distribution. For example, the European Commission has suggested particle number count of 50%, whereas US EPA has suggested >10% by weight (Table 2) .
While the number count approach may seem intuitive when speaking of particulate substances (Bleeker et al., 2013) , the weight percent approach is more consistent with current detection capabilities and sensitivity of relevant analytical instrumentation, as well as current practices for toxicological evaluations and establishment of occupational exposure limits. Current nanoparticle metrology standards have been largely focused on mass and A B Fig. 1 . Particle size distribution considerations. (A) Hypothetical size distribution of two simple particle populations with the same mean particle size but different overall size distributions. (B) A hypothetical particle size distribution highlighting that a substance with a mean particle size greater than 100 nm may still have a portion of the particle population less than 100 nm. volume interpretations, and there have been limited efforts to validate particle count distributions that go below 100 nm (Brown et al., 2013) . Despite this limitation, it has been noted that a focus on mass or volume as part of a distributional threshold may result in larger particles skewing the distribution and an overall underestimate of the true size distribution (Bleeker et al., 2013) . Such a situation would be most applicable for non-homogenous or multimodal populations of particulate substances and could be addressed by specific analysis guidance. It is also true in that a distribution based on particle number will skew the distribution toward the smallest particles. While number count may be more inclusive in terms of defining substances as nanomaterials, the lack of analytical approaches and examples of how it can be applied effectively does not allow for an evaluation of the true utility of such an approach. Using a number count criterion may result in the inclusion of materials that have mass-based distributions much greater than 1000 nm and would never be intended for inclusion as part of a discussion of nanomaterials. For example, under the European Commission's recommendation for a definition (EC, 2011a), which includes particulates having 50% of particles by number below 100 nm, millimeter sized ball bearings containing a trace amount of sub-100 nm wear debris could be classified as a nanomaterial, whereas a population of relatively monodisperse particles with a median diameter of 110 nm may not meet the definition (Brown et al., 2013) . Issues with contamination have also been highlighted with air, water, and even laboratory vessels where sub-100 nm particles may be present in low mass but high numbers (Brown et al., 2013) . These examples illustrate how a definition based on a number count distribution cut-off may result in the inappropriate identification of materials, which could impact the practical implementation of such an approach. Arguments for using particle number-based cut-offs in nanomaterial definitions are based on the concept, supported by some experimental findings over a number of years, that biological effects caused by particulates tend to correlate more closely with the administered dose expressed as particle number or total surface area rather than as mass (Tsuji et al., 2006; Wittmaack, 2007) . However, examination of the more recent literature reveals differing opinions on the appropriate dose metric for describing the biological or toxicological effects of nanomaterials. Data have been presented to show that doseeresponse relationships with nanomaterials can be appropriately defined by particle mass or volume (Pauluhn, 2009 (Pauluhn, , 2010 . Other studies have suggested that total particle surface area may be an appropriate metric (Stoeger et al., 2006) , while others have suggested that mass or surface area can be effective descriptors depending on the material (Ho et al., 2011) .
Another consideration for selection of the dose-metric is the intended use of the dose characterization. For comparison of dose within a given particle type and size, any of the dose-metric options would likely be sufficient. However, there is still uncertainty about the toxicologically relevant dose-metric when comparing dose across classes of particle types and size range. In these cases, it has been suggested that particle numbers or surface area may be the relevant choice (OECD, 2012) .
Interestingly, in the area of occupational exposure limits, discussions on particle number versus mass measurements have previously been addressed, and it was recognized that the use of mass would be more relevant to defining the health hazard while providing a simpler, less expensive, and more reproducible method than a particle count approaches (Tomb and Haney, 1988) . In addition, a recent workshop on occupational exposure limits (OELs) for nanomaterials indicated that mass-based sampling and related analytical methods are viewed as the most practical means for routinely monitoring airborne particulates in the workplace (Gordon et al., 2014) . These factors are expected to drive OEL development for nanomaterials towards mass-based measurement values.
The analytical challenges of determining whether a material meets the particle number-based EC definition have been recently reviewed, the primary obstacle being the lack of standardized, validated methods (JRC, 2014) . Specific technical challenges of number-based particle analyses identified in the JRC report include: sample preparation techniques which can change the size distribution; obtaining representative samples; counting primary particles within aggregates; determining the adequacy of dispersion methods for powder; choosing the most appropriate size metric for non-spherical particles (e.g., minimum external dimension, equivalent sphere, etc.); and suitability of standard reference materials. Other obstacles include the lack of interlaboratory proficiency testing to identify laboratories which can reliably assess whether a material is a nanomaterial according to the EC definition and the high costs of performing these determinations, especially when electron microscopy is required.
Until this issue is resolved, some have recommended that toxicological studies of nanomaterials include the characterization of particles in a manner that allows for conversions between different metrics. While this may seem reasonable, it is important to recognize that laboratory instruments used to measure particle mass or volume often employ mathematical conversions to derive particle count information and that, for these instruments, a 1% error in the ability of a method to accurately describe a mass or volume distribution at the nanoscale could translate to a greater than 50% error in a number distribution (Linsinger et al., 2012; Brown et al., 2013) . Opinions from the Organization for Economic Cooperation and Development (OECD) also recognize that it is appropriate and likely that dose results will continue to be reported in mass-based units and that any deviation from this might have major consequences for the international mutual acceptance of data and would impact classification and labeling where hazards of substances are related to mass concentration (OECD, 2012) .
Based on these considerations, a mass-based distributional threshold is considered more appropriate than a number-based threshold. As with the 100 nm cut-off used for defining nanoobjects in general, the choice of a weight percent cut-off such as 10% is considered a reasonable distributional cut-off that will effectively capture materials of the size range that have been the subject of nanotechnology discussions within various agencies and organizations, while at the same time providing increased clarity for manufacturers and users as to which materials should be included and brought forward for discussion. A 10% weight cut-off is also consistent with the resolution of many of the analytical methodologies that currently exist for particle characterization (Linsinger et al., 2012; Brown et al., 2013) , which will help with the application of definitions. As analytical resolution increases and our collective understanding of the biological and toxicological implications of nanomaterials improves, cut-offs such as 100 nm and 10% by weight may change. In the meantime, the use of these limits allows for a consistent and conservative approach for the assessment of nanomaterials.
Aggregates and agglomerates
Manufacturing processes can have an important impact on the form of particulates and how particles may associate with one another. Nanomaterials are produced by either "top down" or "bottom up" manufacturing approaches (Luther, 2004 ). Most conventional nanomaterial manufacturing processes are "top down" in which a larger sized material is ground or milled to smaller particle sizes. Depending on the amount of energy applied in the process, the final material may range in size from micronscale to nanoscale.
Some graphenes are examples of nanomaterials produced by a "top down" method, in which graphite is mechanically reduced in size to "sheets" of graphene having nanoscale dimensions (Knieke et al., 2010) . Pigments are another example of nanomaterials that are commonly produced by a top down approach.
By contrast, nanomaterials produced by "bottom up" processes are synthesized from atomic or molecular species by chemical reaction(s), allowing the precursor particles to grow in size. Solegel chemistry is an example of this approach in which solid nanoparticles dispersed in a liquid (a solution or sol) agglomerate to form a continuous three-dimensional network extending throughout the liquid (a gel) (Young, 2002) . Thin films and xerogels are examples of nanomaterials produced by the solegel process (Brinker et al., 1992; Durães et al., 2012) . Another type of "bottom up" nanomaterial manufacturing involves high temperature combustion of chemical feedstock to produce airborne molecules which immediately collide to form solid nuclei. During this process, coagulation rates are very rapid, with nuclei sintering or coalescing into spherical primary particles (also called "nodules"). Within milliseconds, the primary particles coalesce (sinter) into larger particles, called aggregates. As the manufacturing process continues, the aggregates collide, resulting in secondary structures, known as agglomerates (Donnet et al., 1993) . Industrial aciniform aggregates (e.g., titanium dioxide, carbon black and some forms of synthetic amorphous silica) are examples of nanostructured materials produced by thermal combustion processes. Fig. 2A illustrates the production of aggregated and agglomerated substances manufactured by a bottom-up high temperature combustion process.
The manufacturing processes described above can produce three different forms of particulates which may exist at the nanoscale: discrete primary particles, aggregates, and agglomerates. Key properties of each form are discussed below and depicted in Fig. 2B . ISO defines a "particle" as a minute piece of matter with defined physical boundaries (ISO, 2008) . Primary particles are considered the smallest discreet entity. They may exist at the nanoscale and are considered to be an indivisible entity. ISO defines an "aggregate" as a particle comprised of strongly bonded or fused particles where the resulting external surface area may be significantly smaller than the sum of calculated surface areas of the individual components. Aggregates may be comprised of constituent primary particles that range in size from nanoscale to greater than 100 nm and, depending on the size and number of the primary particles, aggregates themselves can range in size from the nanoscale to micronscale. It is the size and shape of the aggregates that have a fundamental influence on the properties of the nanomaterial (Donnet et al., 1993) . Importantly, aggregates are robust, essentially indivisible structures, similar to primary particles, in that they cannot be broken down by external forces typically encountered during subsequent handling and processing (Gray and Muranko, 2006) . In contrast, an "agglomerate" is a collection of weakly bound particles, or aggregates or mixtures of the two, and for which the resulting external surface area is similar to the sum of the surface areas of the individual components (ISO, 2008) . Agglomerates are held together by relatively weak forces, such as van der Waals forces or by simple physical entanglement. Therefore, in contrast to aggregates, agglomerates may break down into their constituent entity(s) with sufficient external energy (Donnet, 1993; Gray and Muranko, 2006) . Agglomerates themselves can vary in size but are typically greater than 100 nm.
Most definitions specifically include aggregates and agglomerates (Tables 1 and 2) . Although aggregates and agglomerates can be much larger than 100 nm, many definitions include these entities based on consideration of the potential for these structures to break down into smaller nanoscale entities if sufficient force is applied. The EU Commission's recommendation on the definition of a nanomaterial notes "agglomerated or aggregated particles may exhibit the same properties as the unbound particles (EC, 2011a). Moreover, there can be cases during the life-cycle of a nanomaterial where the particles are released from the agglomerates or aggregates." This concern merits scientific examination. Gray and Muranko (2006) investigated the robustness of two different industrial aggregates (synthetic amorphous silica and carbon black) by evaluating the mechanical forces needed to break down the aggregate structure. They concluded that despite the extreme processing of aggregate materials, there was no significant liberation of nodules (primary particles), although there was some reduction in size of aggregates by internal fracture. The fracturing was reported to occur at weak spots in the necks between nodules. Continued application of mechanical energy did further reduce aggregate dimension once the weak necks had been fractured. Thus, in the aggregate materials studied, the fusing together of primary particles within aggregate structures is tight and strong and therefore the aggregates represent robust discreet particulates. The authors further concluded that aggregate structures that are able to withstand these intense mechanical forces are unlikely to be broken down in a biological system in which forces are very weak by comparison.
This conclusion is supported by the work of Maier et al. (2006) who investigated whether lung surfactant may promote disaggregation of titanium dioxide particles. They evaluated whether the energy of interaction between the main component of lung surfactant and titanium dioxide is sufficient to split the bonds between primary particles of titanium dioxide aggregates and/or the bonds between aggregates of titanium dioxide agglomerates. Using mathematical modeling, they determined that the interaction energy is insufficient to split the bonds. To validate the mathematical model, the authors measured the particle size distribution of titanium dioxide suspensions in simulated lung fluid over time and found no appreciable change in the particle size distribution, indicating that the titanium dioxide did not break down in the simulated lung fluid. The authors conclude that lung surfactant does not promote the disaggregation of titanium dioxide aggregates or agglomerates.
Using various exposure modes (i.e. intratracheal instillation and the inhalation of aerosols with nano-sized or microsized particles), Creutzenberg et al. (2012) investigated the fate of nanoparticle agglomerates after uptake in the lung and found a tendency of nanoscale particles to form larger size agglomerates following deposition and interaction with cells of the respiratory tract. The authors concluded that an increase in particle number due to a disintegration of agglomerates does not seem to be of high biological relevance.
Less work has been done in environmental systems, but the results found in mammalian studies are generally applicable to environmental media. The energy found in environmental settings is not sufficient to break apart aggregates, though it has been demonstrated that agitation in combination with surfactancy and contributions to ionic strength provided by natural organic matter can cause some agglomerates to break apart (Brant et al. 2005 ; See also Taurozi et al., 2011) .
Overall, given the current scientific literature, the inclusion of aggregates and agglomerates in a regulatory definition may not always be warranted. Specifically, aggregates that have been shown not to break down into smaller forms under normal industrial processing or anticipated use conditions should not be treated as discreet nanomaterials for assessment purposes. These aggregates may have biological properties that are effectively represented by larger-scale or bulk forms of the same material. These concepts should be considered in the overall identification and assessment of nanomaterials and will be important in read-across assessments.
Solubility
Solubility in biological and ecological media is another important consideration in the evaluation of nanomaterials because it helps distinguish between characteristics of the material that are based on molecular identity alone and characteristics that are influenced by particle behavior, such as surface activity. Most current definitions do not consider solubility although the importance of solubility is recognized in the global guidance document from the International Council on Cosmetic Regulations (ICCR) (Rauscher et al., 2012) and is incorporated into the European Commission Cosmetics Directive definition (EC, 2009 ).
Solubility has not been explicitly defined for nanomaterials. Without a fundamental definition of solubility to identify which nanomaterials would be soluble and which would not, a practical approach may be to use existing guidelines of classifying solubility such as used by the EC's Scientific Committee on Consumer Safety (SCCS) in their Guidance on the Safety Assessment of Nanomaterials in Cosmetics (SCCS, 2012) . Using this approach, poorly soluble materials are classified as having an aqueous solubility of less than 1 mg/L. The corollary of that would be substances equal to or greater than 1 mg/L would be considered soluble.
Rapid dissociation of particles to ions or molecules would indicate that the toxicology of the particle (and the assessment of risk) should be based primarily on the molecular identity (SCENIHR, 2007) rather than properties of the particle (surface reactivity or crystallinity, for example). The properties of materials that quickly dissociate in biological or ecological fluids are likely to be dominated by the properties of the molecular and/or ionic form. They will be absorbed, distributed, and eliminated as the molecular form, while those that dissociate slowly will primarily behave as particulates. For example, zinc oxide and cadmium selenide (quantum dots) particles have been shown to dissociate into ions (Hardman, 2006; Xia et al., 2008; Gulson et al., 2010; Galeone et al., 2012) , and the dissociated ions thereby contribute to the biological properties of the particles. When considering solubility for regulatory purposes, the kinetics of dissolution will be important rather than total solubility at equilibrium. The rate of solubility will determine the amount and form of substance available for possible biological activity from the time the material is inhaled to when it is cleared. While a less common phenomenon, it should be noted that for some materials, nanoparticles can form from dissolved species under ecological conditions (Slowey, 2010; Akaighe, 2011) .
The relationship between dissolution and mechanical clearance mechanisms has been well studied and shown to be important for predicting the biological effects of inhaled particulate and manmade fibers (Fig. 3) (Oberd€ orster, 1989; Davis, 1994; Oberd€ orster Fig. 3 . Pulmonary clearance of inhaled particulates. Pulmonary clearance of particles can be achieved through dissolution or mechanical clearance which can impact the overall toxicity of the material. Mechanical clearance includes particle transport by mucocilliary activity (primarily upper respiratory), phagocytosis by macrophages and migration via the mononuclear phagocyte system, or direct translocation of particles though respiratory epithelium. Borm et al., 2006) . In this context, mechanical clearance includes particle transport by mucocilliary activity (primarily upper respiratory), phagocytosis by macrophages and migration via the mononuclear phagocyte system, or direct translocation of particles though respiratory epithelium. As an example, consider the difference in potential biological effects between three nanoscale materials: sea salt (NaCl), zinc oxide (ZnO) and titanium dioxide (TiO2). The salt will dissociate almost instantly upon inhalation and contact with the mucosa. The pattern of dissociation of ZnO particles is more complex but eventually leads to some proportion of solubilization (Lopes et al., 2014) , while the nanoscale TiO2 is essentially insoluble with a half-life of weeks in the lung (Oberd€ orster et al. 1994 , Bermudez et al. 2004 ). The clearance of inhaled particulate NaCl begins with rapid dissolution followed by absorption and elimination of the solubilized ions. Clearance of ZnO is initially by a combination of mechanical means and through dissolution, while TiO2 clearance is almost exclusively by mechanical means due to its limited solubility in biological fluids (Bermudez et al., 2004) . The physical form of the sea salt exposure is largely unimportant to the biological effects since it is immediately dissociated into its ionic components while the effects of the TiO2 will be determined primarily by its physical form. The potential effects of inhaled ZnO will be a mix of particle effects (initially) and the effects from the ionized form of Zn produced by the dissolution. Thus, the consideration of solubility and dissolution rate is important in distinguishing between materials that have the potential for displaying size-dependent particulate effects and those materials whose effects are due to the molecular form regardless of their initial physical particulate form.
Factors that affect dissolution include composition of the medium, ionic strength, temperature, pH, and the presence of ligands, such as proteins, lipids, or formed elements in the blood, that can preferentially bind to the nanomaterial and shift the kinetics of clearance (Rauscher et al., 2012) . Surface architecture, coatings, and agglomeration state also influence dissolution (Borm et al., 2006; Rauscher et al., 2012) . Thus, evaluating the extent and rate of dissolution is not trivial. Unfortunately, there are no standards for defining solubility relative to the rate of dissolution. Categorical statements such as "insoluble" have little meaning for solid particles. Indeed, there is little agreement about what soluble/insoluble and slow/rapid clearance mean with reference to inhaled particles. For example, amorphous silica has a half-life in the lungs of rats of around 50 days yet it is said to be cleared "rapidly" mainly by "dissolution" in lung fluid (Fruijtier-Polloth, 2012) . Instead, the rate of dissolution may be more valuable in characterizing whether a particle remains intact or dissociates into components that may drive further assessment.
Because the biological effects of materials that rapidly dissolve in biological fluids are primarily related to their chemical properties and not their physical form, they would not appear to warrant additional regulatory interest beyond that given to the non-nano form of the same materials. Presumably, larger-scale soluble inhaled particles will pass through the nanoscale size range as they dissolve and would exhibit the biological effects relevant to the nanoscale form. Thus, the toxicological information from the larger particles may also be relevant to the toxicology of the nanoscale form. Ultimately, solubility and dissolution are important factors that need to be considered in the assessment of nanomaterials.
Intentionally manufactured nanomaterials
Nanoscale particles are not new to nature. They have been ubiquitous from the formation of the earth to the present, and we are constantly surrounded by nanoparticles. For example, the air we breathe contains tens of thousands of nanoparticles per cubic centimeter (Buzea et al., 2007; Hochella et al. 2008; Slezakova et al. 2013) . Some of these nanoparticles are incidental particulates of man-made origin such as combustion products from the burning of coal and petroleum products, residues from abrasion, and even baking. Many others are of natural origin, coming from weather, volcanic dust, sea spray, and natural combustion sources such as forest fires. The volume of naturally occurring nanomaterials far exceeds the volume of those produced from man-made sources (Buzea et al., 2007) . While it is recognized that some very small particles can cause health concerns due their composition and/or concentration in air, more than the simple presence of very small particles is needed to focus attention on these materials.
We recommend that a core element of any definition for nanomaterials in commerce include only those nanomaterials that are intentionally manufactured (i.e., engineered). Inclusion of this element would avoid inappropriate focus on nanomaterials that are produced incidentally and those from natural sources, allowing stakeholders to focus on materials that are intentionally manufactured at the nanoscale to have specific properties. ISO (2010) provides useful definitions for two types of nanomaterials, manufactured and engineered. A manufactured nanomaterial is intentionally produced for commercial purposes to have specific properties or specific composition (e.g., transparency). An engineered nanomaterial is designed for specific purpose or function (e.g., quantum dots).
In each case, the intent of manufacturers is to take advantage of properties the nanomaterial provides based on its size. Hence it is appropriate to consider intentional manufacture as a core element in the assessment of the nanomaterial. Most current definitions include this important element (Table 2) , but we believe it is one that should be adopted uniformly.
Size-dependent properties of nanomaterials
Nanomaterials are typically developed and used to take advantage of size-dependent properties that do not exist for comparable materials of larger sizes and are therefore considered unusual or novel. For some nanomaterials there are properties that are size-dependent and are not easily predictable based on the properties of larger forms of the same material. From Auffan et al. (2009) , examples include:
The melting point of tin is 232 C when its particle size is >100 nm but at a particle size of 6 nm, its melting point is only 14 C. Cadmium selenide is normally a semiconductor, but when formed into a 5e10 nm quantum dot the movement of electrons is much more limited (quantum confinement) resulting in the generation of intense size-dependent visible light emissions (fluorescence) of a narrow band of wavelengths (color) when excited by less intense white or blue light. Gold is generally considered to be chemically inert, making it an ideal material in many applications such as electronic connections and jewelry. Interestingly, gold becomes catalytic when its particle size is reduced to the nanoscale.
In contrast, many nanomaterials do not exhibit unusual or novel properties when compared to their larger scale forms. An example of a size-dependent property that is not unusual is a change in surface area compared to mass. This property is easily determined both analytically and mathematically, and, for a given mass, smaller particles have more surface area than larger particles. An application of this property is in absorption, where high surface area solid materials can be used to absorb more liquid than a comparable amount of low surface area material. Another example is in reinforcing agents where solid materials can be added as strengthening agents in plastics, and smaller sized materials provide more strength for a given mass than larger particles. As noted, this property is size-dependent but is not novel or unusual (Fu et al., 2008) .
From an assessment standpoint, the important issue is whether the nanomaterial has biologically relevant size-dependent properties that differ from those of the same material at a larger scale and which make read-across of toxicological data from the larger material questionable. Some size-dependent properties may have little or no relevance for hazard identification (e.g., melting point, color), while others may be highly relevant (e.g., surface area activity, solubility). Therefore, we recommended that nanomaterial evaluation frameworks focus on nanomaterials that have unusual (i.e., not readily predictable) size-dependent properties that may merit additional review.
Many definitions already include the concept of "novel" or "unique" properties or "nanoscale phenomena" (Tables 1 and 2) . However, most current definitions provide little or no guidance as to which properties should be considered novel and unique for hazard assessment purposes and fail to adequately consider the difficulties entailed in accurately measuring these properties. For example, surface reactivity is frequently mentioned as an important contributing factor to the (eco)toxicity of nanomaterials. However, there is no consensus on the most appropriate methods for measuring surface reactivity, and available methods may be prone to artifacts and misinterpretations (Horst et al., 2013; Petersen et al., 2014) . Some definitions include extension of these unusual properties to materials greater than 100 nm in size, and it is recommended that in these cases the definition guidance should clearly indicate the basis for the inclusion of larger materials. Overall, additional discussion and clarity in this area is critical to ensure consistency and transparency in the identification and assessment of nanomaterials.
Discussion
Taken together, the elements discussed abovedparticle size, a distributional threshold, intentional manufacture, the state of agglomeration/deagglomeriation and aggregation/disaggregation, solubility/dissolution rate and precipitation/reformation, and relevant size-dependent propertiesdrepresent important components that should be considered when discussing nanomaterial definitions or establishing evaluation frameworks. Purely technical nanomaterial definitions based only on particle size, such as ISO's definition (ISO, 2008) , are not useful from a safety evaluation standpoint because they can include virtually every substance that may exist in particulate form. Nanomaterial evaluation frameworks should be established to help to narrow the scope to those nanoscale materials that may merit additional evaluation for purposes of protecting human health and the environment while at the same time having appropriate clarity of scope and being practical to implement.
Each of the elements discussed in this paper is included in one or more of the definitions we reviewed; however, they are not used consistently and often differ in the scope specified by a particular element. As a result, a substance considered a nanomaterial under one regulatory scheme may not be considered a nanomaterial in another. Such inconsistency creates considerable difficulty for nanomaterial manufacturers and users in complying with multiple regulatory requirements and may lead to the perception among customers and the public that nanomaterials are not being adequately evaluated or regulated. As governmental authorities consider moving forward with discussions on nanomaterial definitions and risk evaluation frameworks, they should strive for greater alignment and consistency in what is considered to be a nanomaterial. Consistency will be instrumental for ensuring the transparent identification of materials that warrant additional consideration, stakeholder confidence in the current regulatory frameworks, and continued development of nanotechnology.
It is also important to give adequate consideration to ongoing developments in research that informs the human health and environmental assessment of nanomaterials. Many of the initial concerns regarding nanotechnology revolved around uncertainties concerning the potential impact of nanomaterials on human health and the environment. From a regulatory perspective, there were two key areas of concern: (1) whether hazard, exposure, and risk assessment methods used for other materials can be applied to nanomaterials, and (2) whether existing regulatory frameworks, which do not distinguish materials on the basis of size, can ensure proper identification, review, and regulation of nanomaterials.
The first concern about the applicability of hazard assessment approaches for other materials was largely based on concerns that nanomaterials might harbor unknown modes of toxicity or exhibit nano-specific biological effects that would not be detected through the use of current hazard evaluation approaches. Today there is an extensive and growing body of research on nanomaterial toxicity that addresses this concern. One of the most comprehensive efforts has been implemented through the OECD, which launched a program of work to ensure that the approaches for hazard, exposure, and risk assessment are appropriate for the evaluation of nanomaterials (OECD, 2006) . The methods and approaches considered are applicable to human, animal, and environmental situations. Preliminary conclusions from this work have indicated that current approaches for the testing and assessment of traditional chemicals are appropriate for assessing the safety of nanomaterials (OECD, 2009; OECD, 2012) . It is acknowledged that certain test methods may need to be adapted to allow for appropriate compatibility with nanomaterials. This is in alignment with a recent perspective which indicated that there is no evidence that nanomaterials exhibit novel mechanisms of toxicity and that conventional particle toxicology data are useful for the determination of nanoparticulate hazard potential (Donaldson and Poland, 2013) . Such conclusions represent important advancements in our understanding of nanomaterials and should be considered as discussions on safety evaluation and the need for definitions continue to evolve.
With respect to the second concern, the ability of current regulatory frameworks to ensure proper identification and review of nanomaterials, the OECD has recommended that its member countries apply existing international and national frameworks to manage any risks associated with the manufacture and use of nanomaterials (OECD, 2013b) . As part of its recommendation, OECD notes that current frameworks may need to be adapted; however, completely new frameworks are not needed for nanomaterials. Efforts in the OECD are now focused on nanomaterial evaluation approaches including those related to identification, characterization and read-across assessment approaches (OECD, 2013a) .
While the discussion on elements of nanomaterials that may be important for safety evaluation is important, we believe many groups have focused on the development of definitions for identification of nanomaterials without consideration of how they will be used. If definitions are developed, they should be developed in conjunction with plans for implementation. In this sense, demonstration of how definitions would be applied through the use of case studies may be informative. Without such a parallel strategy, it is difficult to understand the true scope of the definition or how specific elements of the definition can best be addressed, especially considering the complex analytical characterization that may be required.
This concept was introduced, in part, within the European Commission recommendation (EC, 2011a), which states that the recommendation should be used as a reference for determining whether a material should be considered as a "nanomaterial" for legislative and policy purposes. The Commission appears to recognize that its recommendation should not simply be implemented as written, but that individual regulations may have unique requirements that a single, rigid definition may not satisfy. The Commission also states that the identification of a nanomaterial should not prejudge or reflect the scope of legislation or provisions for potentially establishing additional requirements for nanomaterials, including those relating to risk management. The Commission goes on to state that in some cases it may be necessary to exclude materials from the scope of any legislation even if they fall within the definition (EC, 2011). These statements clearly indicate that implementation of the definition as part of an evaluation framework will require additional guidance and scope refinement.
A recent example of the complexity associated with implementing a regulatory definition can be seen with the French Registry for nanomaterials. The registry requires reporting of nanomaterials marketed in France and leverages the European Commission's recommended definition (ANSES, 2012) . Implementing the registry required extensive additional guidance beyond the definition to determine what was within scope and therefore reportable. Initial guidance was supplemented by extensive question and answer documentation during the actual reporting process. For example, one point of clarity focused on the definition term "intentionally manufactured" which was to indicate the deliberate manufacturing of a substance at the nanoscale and excluded nanomaterials that may be unintentional by-products of the synthesis process. Another point of clarity was provided on the lack of a need to declare a substance if it was bound in a mixture from which it was not expected to be released or extracted under normal or foreseeable conditions of use. This exclusion highlights the consideration of release and/or exposure potential as part of the framework for identification of materials, which is an important component in the evaluation of potential downstream risk. This example represents the activity of a single country within the European Union, but additional country-specific registries have been implemented (Tables 1 and 2) . Clearly, any variation on the use of definitions and how they are implemented within and among different regions can lead to inefficiency, inconsistency, and miscommunication.
An additional example illustrating the challenge of a regulatory definition comes from a proposed rule issued by the US Environmental Protection Agency (US EPA, 2011a). The Agency proposed a rule that sought to obtain information pertaining to the use of nanomaterials in pesticide products. However, it was noted in one of the public comments that the lack of clarity in how the Agency defined a nanomaterial at that time would make it difficult for those who develop pesticide products to know if their materials were considered to be nanomaterials (ACC, 2011) . The authors of the response recommended that the Agency consider developing a more clear definition using many of the concepts explained above.
These examples highlight the difficulty of implementing a definition, which in turn provides support for considering the Fig. 4 . Example approach for implementation of a nanomaterial definition into a regulatory decision framework. The framework starts with the definition from the regulatory authority and moves beyond identification towards a framework for assessment. Importantly, regardless of the definition used, all substances and materials should be appropriately evaluated to ensure that they are safe for their intended uses. While definitions may not incorporate all of the elements that are described above, we believe that the elements presented in this paper (listed on the left of the figure) should be considered at some point during the evaluation process to determine if the material requires additional regulatory review.
regulatory implementation of a definition as part of the development process. Implementation of a definition without integration into a regulatory framework results in the identification of a list of materials without purpose or action, which could lead to unnecessary stigmatization of nanomaterials as a whole. The potential for formation of such perspectives is well-recognized and specifically highlighted as an area of concern within a White House memorandum on regulatory frameworks for nanomaterials (Holdren, 2011) . The memorandum notes that agencies should avoid making unfounded generalizations that categorically judge nanomaterials as intrinsically benign or harmful. Importantly, nanomaterials are not inherently hazardous, and therefore definitions and frameworks that intend to identify nanomaterials should be established to avoid such generalizations and avoid establishing nanomaterial inventories without purpose. Even for those nanomaterials for which health or environmental hazards have been identified, it is important to recognize that the actual health or environmental risk will be determined by the potential for exposure to the material. The concept of considering both hazard and exposure as a determination of risk is inherent in the regulatory process and should be maintained for the assessment of nanomaterials.
Ultimately, if a definition or definition system for identifying nanomaterials is needed, its application within the current assessment framework should be addressed. An example of how a nanomaterial definition can be incorporated into a risk-based assessment framework is presented in Fig. 4 . The first step is to determine whether the substance falls into the scope of interest for nanomaterials. If a material meets the criteria for a potential nanomaterial (which may be specified by certain definition elements), the next step should be to determine whether it is a new or existing chemical substance according to the applicable regulations. If the nanomaterial is a new substance, the manufacturer or importer must follow the standard notification and registration process to ensure that the nanomaterial undergoes regulatory review. Registrations of new nanomaterials should include available information that may be relevant to the evaluation of potential hazards and risks.
If the nanomaterial is considered an existing chemical substance under the applicable regulations, the next level of assessment should be to determine whether existing toxicology and/or safety data for the nanomaterial (or the larger form of the same material) are available and adequate for assessing potential human health or environmental risks under anticipated or foreseeable exposure scenarios. Examples of existing nanomaterials for which robust toxicology datasets are available include carbon black, synthetic amorphous silica, and zinc oxide, all of which have been used for decades and evaluated in numerous toxicological and epidemiological studies. The potential risks and appropriate safe handling practices for these so-called "historical" nanomaterials are well understood. Except in unusual cases (e.g., a previously untested route of exposure), additional regulatory review of these nanomaterials would seem to offer little added value and divert scarce resources. This concept is consistent with existing perspectives that some materials should be excluded from any developing nanomaterial legislation (EC, 2011) .
If the nanomaterial does not have a specific toxicological data set sufficient for evaluating potential risks, the next consideration is whether the nanoscale material possesses novel size-dependent properties relative to larger forms of the same material and, if so, whether such properties could plausibly influence the hazard/ exposure/risk profile of the nanomaterial relative to its larger forms. As discussed previously, some nanomaterials do not possess novel size-dependent properties (i.e., ones not readily predictable based on simple size scaling), and some novel properties (e.g., color differences observed at the nano-scale) have no known or plausible correlation to hazard or risk. Additional elements could also be considered at this stage (if not previously addressed as part of the scoping stage), including solubility/dissolution and impact of aggregation/agglomeration. Doing so provides an opportunity to evaluate the material with consideration of the ability to use readacross approaches to predict the hazards/risks of the nanomaterial based on available information from the larger-scale material. As noted previously, the size boundaries for defining nanomaterials are arbitrary, and many material properties are predictable and scalable as their size decreases from >100 nm to smaller sizes. On the other hand, if a nanomaterial possesses novel size-dependent properties that could plausibly influence hazard or risk, readacross from the larger-scale material may be inappropriate, and additional information on the nanomaterial should be gathered or generated.
Throughout this proposed approach and regardless of the definition used, it is critical at each stage of the evaluation process to ensure confidence in the hazard and risk assessment of the substance, consistent with good product stewardship and the principles of Responsible Care ® , to ensure that all substances are safe for their intended use (ACC, 2014; ICCA, 2014) . Furthermore, it is acknowledged that more detailed guidance than that presented here will be necessary as part of a nanomaterial evaluation framework, regulatory or otherwise (e.g., Environmental Defense Fund and DuPont, 2007; Oomen et al., 2014) . While emerging definitions may not incorporate all of the elements that are described above, we believe that the elements presented in this paper should be considered at some point during the evaluation process to determine if the material requires additional review.
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